Globeflex Capital L P purchased a new stake in shares of Pharmerica Corporation (NYSE:PMC) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 8,317 shares of the company’s stock, valued at approximately $218,000.

Other hedge funds have also made changes to their positions in the company. SG Americas Securities LLC purchased a new stake in shares of Pharmerica Corporation during the 1st quarter valued at approximately $121,000. Russell Investments Group Ltd. lifted its stake in shares of Pharmerica Corporation by 124.5% during the 2nd quarter. Russell Investments Group Ltd. now owns 4,886 shares of the company’s stock valued at $128,000 after buying an additional 2,710 shares in the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Pharmerica Corporation by 79.8% during the 2nd quarter. State of Alaska Department of Revenue now owns 6,112 shares of the company’s stock valued at $160,000 after buying an additional 2,712 shares in the last quarter. US Bancorp DE lifted its stake in shares of Pharmerica Corporation by 41.3% during the 1st quarter. US Bancorp DE now owns 7,121 shares of the company’s stock valued at $167,000 after buying an additional 2,081 shares in the last quarter. Finally, Mason Street Advisors LLC lifted its stake in shares of Pharmerica Corporation by 7.0% during the 1st quarter. Mason Street Advisors LLC now owns 7,200 shares of the company’s stock valued at $168,000 after buying an additional 474 shares in the last quarter. Institutional investors own 92.15% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/09/30/8317-shares-in-pharmerica-corporation-pmc-purchased-by-globeflex-capital-l-p.html.

A number of brokerages recently commented on PMC. Zacks Investment Research cut shares of Pharmerica Corporation from a “buy” rating to a “hold” rating in a research note on Tuesday. ValuEngine cut shares of Pharmerica Corporation from a “buy” rating to a “hold” rating in a research note on Friday, September 22nd. Barrington Research cut shares of Pharmerica Corporation from an “outperform” rating to an “underperform” rating in a research note on Thursday, August 3rd. KeyCorp cut shares of Pharmerica Corporation to an “overweight” rating in a research note on Tuesday, August 8th. Finally, Credit Suisse Group cut shares of Pharmerica Corporation from an “outperform” rating to a “neutral” rating and increased their target price for the stock from $29.00 to $29.25 in a research note on Friday, August 4th. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $30.50.

Shares of Pharmerica Corporation (NYSE PMC) opened at 29.30 on Friday. The firm has a 50-day moving average of $28.94 and a 200 day moving average of $25.67. The stock has a market capitalization of $911.85 million, a PE ratio of 39.70 and a beta of 0.84. Pharmerica Corporation has a 1-year low of $19.20 and a 1-year high of $29.40.

Pharmerica Corporation (NYSE:PMC) last posted its quarterly earnings results on Wednesday, August 2nd. The company reported $0.47 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.47. The business had revenue of $592.00 million during the quarter, compared to analyst estimates of $592.96 million. Pharmerica Corporation had a net margin of 1.05% and a return on equity of 10.94%. The company’s revenue was up 13.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.47 earnings per share. Analysts predict that Pharmerica Corporation will post $1.94 EPS for the current year.

Pharmerica Corporation Profile

Want to see what other hedge funds are holding PMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pharmerica Corporation (NYSE:PMC).

Institutional Ownership by Quarter for Pharmerica Corporation (NYSE:PMC)

Receive News & Stock Ratings for Pharmerica Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharmerica Corporation and related stocks with our FREE daily email newsletter.